JAMA Neurology : Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
May 5, 2025
21:13
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.
JAMA Network